Data updated: Mar 29, 2026

PLIVA LACHEMA

Oncology

Generics

PLIVA LACHEMA is a generic drug manufacturer focused on Oncology.

2008

Since

4

Drugs

-

Trials

30

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

CARBOPLATIN 2026-02-04

OXALIPLATIN 2026-01-15

OXALIPLATIN 2025-10-22

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

IRINOTECAN HYDROCHLORIDE 2025-08-20

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

Baxter specialty

AbbVie big-pharma